Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group

导出原文传递

翻译打印收藏纠错

作者： Winqvist, Maria ^[1] ; Asklid, Anna ^[2] ; Andersson, P. O. ^[3] ; Karlsson, Karin ^[4] ; Karlsson, Claes ^[5] ; Lauri, Birgitta ^[6] ; Lundin, Jeanette ^[7] ; Mattsson, Mattias ; Norin, Stefan ; Sandstedt, Anna ; Hansson, Lotta ; Osterborg, Anders

作者单位： Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden ^[1] Skane Univ Hosp, Dept Hematol & Vasc Disorders, Lund, Sweden ^[2] Sunderby Hosp, Dept Hematol, Sunderbyn Lulea, Sweden ^[3] Linkoping Univ Hosp, Dept Hematol, Linkoping, Sweden ^[4] Univ Uppsala Hosp, Dept Hematol, Uppsala, Sweden ^[5] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden ^[6] South Alvsborg Hosp, Dept Hematol, Boras, Sweden ^[7]

发布时间 2017-04-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Haematologica

2016年101卷12期

1573-1580页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group

Haematologica

相似文献

Haematologica

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group

Haematologica

相似文献

Haematologica

相关期刊

检索历史清除